Melnik Bodo C
Department of Dermatology; Environmental Medicine and Health Theory; University of Osnabrück; Osnabrück, Germany.
Dermatoendocrinol. 2011 Jul;3(3):141-65. doi: 10.4161/derm.3.3.15331. Epub 2011 Jul 1.
Oral isotretinoin (13-cis retinoic acid) is the most effective drug in the treatment of acne and restores all major pathogenetic factors of acne vulgaris. isotretinoin is regarded as a prodrug which after isomerizisation to all-trans-retinoic acid (ATRA) induces apoptosis in cells cultured from human sebaceous glands, meibomian glands, neuroblastoma cells, hypothalamic cells, hippocampus cells, Dalton's lymphoma ascites cells, B16F-10 melanoma cells, and neuronal crest cells and others. By means of translational research this paper provides substantial indirect evidence for isotretinoin's mode of action by upregulation of forkhead box class O (FoxO) transcription factors. FoxOs play a pivotal role in the regulation of androgen receptor transactivation, insulin/insulin like growth factor-1 (IGF-1)-signaling, peroxisome proliferator-activated receptor-γ (PPArγ)- and liver X receptor-α (LXrα)-mediated lipogenesis, β-catenin signaling, cell proliferation, apoptosis, reactive oxygene homeostasis, innate and acquired immunity, stem cell homeostasis, as well as anti-cancer effects. An accumulating body of evidence suggests that the therapeutic, adverse, teratogenic and chemopreventive effecs of isotretinoin are all mediated by upregulation of FoxO-mediated gene transcription. These FoxO-driven transcriptional changes of the second response of retinoic acid receptor (RAR)-mediated signaling counterbalance gene expression of acne due to increased growth factor signaling with downregulated nuclear FoxO proteins. The proposed isotretinoin→ATRA→RAR→FoxO interaction offers intriguing new insights into the mode of isotretinoin action and explains most therapeutic, adverse and teratogenic effects of isotretinoin in the treatment of acne by a common mode of FoxO-mediated transcriptional regulation.
口服异维A酸(13 - 顺式维甲酸)是治疗痤疮最有效的药物,可恢复寻常痤疮的所有主要致病因素。异维A酸被视为一种前体药物,在异构化为全反式维甲酸(ATRA)后,可诱导人皮脂腺、睑板腺、神经母细胞瘤细胞、下丘脑细胞、海马细胞、道尔顿淋巴瘤腹水细胞、B16F - 10黑色素瘤细胞和神经嵴细胞等培养的细胞发生凋亡。通过转化研究,本文提供了大量间接证据,证明异维A酸通过上调叉头框O类(FoxO)转录因子发挥作用。FoxO在雄激素受体反式激活、胰岛素/胰岛素样生长因子-1(IGF - 1)信号传导、过氧化物酶体增殖物激活受体-γ(PPArγ)和肝X受体-α(LXrα)介导的脂肪生成、β - 连环蛋白信号传导、细胞增殖、凋亡、活性氧稳态、先天和后天免疫、干细胞稳态以及抗癌作用的调节中起关键作用。越来越多的证据表明,异维A酸的治疗、不良、致畸和化学预防作用均由FoxO介导的基因转录上调介导。这些由FoxO驱动的维甲酸受体(RAR)介导信号的二次反应转录变化,通过下调核FoxO蛋白增加生长因子信号传导,从而平衡痤疮的基因表达。所提出的异维A酸→ATRA→RAR→FoxO相互作用为异维A酸的作用方式提供了有趣的新见解,并通过FoxO介导的转录调节的共同模式解释了异维A酸在治疗痤疮中的大多数治疗、不良和致畸作用。